Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
about
The emerging role of FTY720 (Fingolimod) in cancer treatmentSphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progressPAK1 is a novel cardiac protective signaling moleculeThe differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion.Cardiovascular effects of fingolimod: A review article.The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signallingImplication of sphingosin-1-phosphate in cardiovascular regulation.Ischemia/Reperfusion injury protection by mesenchymal stem cell derived antioxidant capacity.p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes.Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular diseaseThe potential role of sphingolipid-mediated cell signaling in the interaction between hyperglycemia, acute myocardial infarction and heart failure.Lysophospholipid receptor activation of RhoA and lipid signaling pathways.Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury.Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.Biological Effect of Licochalcone C on the Regulation of PI3K/Akt/eNOS and NF-κB/iNOS/NO Signaling Pathways in H9c2 Cells in Response to LPS Stimulation.A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery.Depletion of PAK1 enhances ubiquitin-mediated survivin degradation in pancreatic β-cells.The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration.The Relationship between Pre-Infarction Angina and Serum Sphingosine-1-Phosphate Levels.PAK1 limits the expression of the pro-apoptotic protein Bad in pancreatic islet β-cells.Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes.The art of the deal in myofilament modulation of function.Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype.FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.Ursodeoxycholic acid protects cardiomyocytes against cobalt chloride induced hypoxia by regulating transcriptional mediator of cells stress hypoxia inducible factor 1α and p53 protein.Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts
P2860
Q26748927-DF7B0560-59B9-4584-97B0-A667C29E8157Q27001065-B2038B2D-B377-4D63-A9F3-6E5FEE48E400Q28251952-CCA71C61-CA7C-4606-838A-F66CFA498C46Q33613072-B98ACE3C-DA1C-46D4-973C-AEA15A12EB5EQ34558943-9D94D8D2-80CD-40B3-BD31-48B082795E18Q35879566-25D364C8-C9B0-43F4-BB76-458341A80C8DQ36000867-6FBF2991-07E7-4E79-A11E-EF6019DC33ADQ36072077-FA110CBE-0FC4-48E7-8A46-BD2F2246E267Q36287970-C4215561-3224-4342-86D7-27021CC5CE47Q36898368-EAF0FEF9-9EC7-49FB-A65D-7C363D828427Q37139569-289FF1BE-0E59-4B06-8693-A2ABD02EBF51Q37594666-3653FEC4-EF7A-4E0D-B6DA-2F3CE191ACC2Q37678657-0EE9B353-C0AC-4E8E-BF4E-178B43500ED9Q38023943-1BED09F2-1418-415E-80F6-A9BC0CC98FE0Q38044174-25D16473-B092-4036-ACD4-F1FDDD4A4EB2Q38083851-E7101CEF-4093-4CDD-AE74-FA8CAC6EBB99Q38124049-F688B00D-60EA-4E2B-A450-D41AA405B5D9Q38711071-F5207F4B-6C91-4746-B7B6-863D895CE1DBQ39106527-7C464741-4890-4048-8198-5DC59895C96EQ39178014-76B32552-15CF-42CE-A0AC-D0A6D14C247AQ39345870-F3B21018-5AFF-4F5E-9110-29578C3D1360Q39401262-6BCBD81E-3A88-48F5-9B64-7CF1250415D9Q40319116-AC156FCE-7DE7-459B-9AFC-8F34C1B5CF8DQ42011721-95FDC420-739F-4294-9682-F5B6749586AFQ42495601-6D72F39A-F1C4-4E95-8084-B6DF44B4F762Q43100735-80A96F8D-21FF-42BB-80BF-5D44D38DAD8EQ45763186-C7F292A0-AD3F-44F5-9DAD-E4C35318418FQ46081929-FA53C69F-D470-4104-8E26-148811B19FA6Q46280855-74B00125-43F0-49ED-93E9-55E53ED2361BQ47659026-80D9C5EE-C5C1-4663-9AC0-F1C587DCAB0BQ56366840-8DCF8E0C-84F6-4032-A3C9-F408BF7C82C8
P2860
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activation of Pak1/Akt/eNOS si ...... against ischemic cell injury.
@ast
Activation of Pak1/Akt/eNOS si ...... against ischemic cell injury.
@en
type
label
Activation of Pak1/Akt/eNOS si ...... against ischemic cell injury.
@ast
Activation of Pak1/Akt/eNOS si ...... against ischemic cell injury.
@en
prefLabel
Activation of Pak1/Akt/eNOS si ...... against ischemic cell injury.
@ast
Activation of Pak1/Akt/eNOS si ...... against ischemic cell injury.
@en
P2093
P2860
P50
P1476
Activation of Pak1/Akt/eNOS si ...... s against ischemic cell injury
@en
P2093
Debora Chirico
Elizabeth J Cartwright
Farzin Fath-Ordoubadi
Mohamed Shaheen
R John Solaro
Sally E Stringer
Sanoj Chacko
Tamer M A Mohamed
P2860
P304
P356
10.1152/AJPHEART.01003.2010
P577
2011-06-24T00:00:00Z